Opulantpharmaceuticals

India
Develops API products, intermediates, and specialty chemicals for global pharmaceutical supply.

About Opulantpharmaceuticals

Opulantpharmaceuticals is a Healthcare company based in India. It develops API products, intermediates, and specialty chemicals for global pharmaceutical supply. It operates on a B2B model. The company has 1 employees. Its Indian entity Opulant Pharmaceuticals Private Limited reported revenue of β‚Ή80.6 Lakh. Opulantpharmaceuticals offers products and services including API Products, API Intermediates, and Speciality Chemicals. Its focus areas include Pharmaceuticals, Drug Manufacturing, API Production and Specialty Chemicals.

Company details

Opulant Pharmaceuticals Pvt. Ltd. enhances quality systems to manufacture safe and efficacious drug products, adhering to regulatory standards through a risk-based approach. They supply API products, intermediates, and specialty chemicals, aiming to improve customer quality of life. Based primarily in Hyderabad, India, with a branch in Ho Chi Minh City, Vietnam, they focus on innovation and competence in the pharmaceutical sector.

Key Metrics
  • Annual Revenue
    ₹80.6 Lakh

    FY 2023 · +1122% YoY

  • Net Profit
    ₹27,800

    FY 2023 · 0% margin

  • EBITDA
    ₹60,000

    FY 2023 · 1% margin

  • Employee Count
    1

Products & Services of Opulantpharmaceuticals

Opulantpharmaceuticals offers a comprehensive portfolio of products and services, including API Products, API Intermediates, and Speciality Chemicals.

API Products
Pharmaceutical Manufacturing

Supplies active ingredients for drug production and quality assurance.

API Intermediates
Chemical Intermediates

Provides raw materials used in API manufacturing processes.

Speciality Chemicals
Specialty Chemicals

Offers advanced chemicals for pharmaceutical and research applications.

Board of directors of Opulant Pharmaceuticals Private Limited (Opulantpharmaceuticals)

Opulant Pharmaceuticals Private Limited is the primary company behind Opulantpharmaceuticals. The board of Opulant Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Rakesh Kasula, appointed in 2020.

DirectorDesignationAppointedTenureEntity
Rakesh Kasula
DIN 08871802
Managing Director10 Sep 20206 yrs 2 moOpulant Pharmaceuticals Private Limited
Kasularaghavarao
DIN 08871893
Director10 Sep 20206 yrs 2 moOpulant Pharmaceuticals Private Limited

Financials of Opulantpharmaceuticals

Figures of Opulant Pharmaceuticals Private Limited, the primary company behind Opulantpharmaceuticals, for FY 2023. Revenue was ₹80.6 Lakh (+1122% year on year). Net profit was ₹27,800 (0% margin). EBITDA was ₹60,000 (1% margin).

  • ₹80.6 LakhRevenue · FY 2023 · +1122% YoY
  • ₹27,800Net profit · 0% margin
  • ₹60,000EBITDA · 1% margin
  • ₹15 LakhPaid-up capital

Balance sheet, profit and loss, cash flow and ratios of Opulant Pharmaceuticals Private Limited are on its company page.

Premium access

Detailed financial statements for Opulantpharmaceuticals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Opulantpharmaceuticals

Opulantpharmaceuticals is headquartered in India.

Opulantpharmaceuticals has 1 employees.

The primary company behind Opulantpharmaceuticals, Opulant Pharmaceuticals Private Limited, reported revenue of β‚Ή80.6 Lakh for FY 2023, up 1122% year on year.

Opulant Pharmaceuticals Pvt. Ltd. enhances quality systems to manufacture safe and efficacious drug products, adhering to regulatory standards through a risk-based approach. They supply API products, intermediates, and specialty chemicals, aiming to improve customer quality of life. Based primarily in Hyderabad, India, with a branch in Ho Chi Minh City, Vietnam, they focus on innovation and competence in the pharmaceutical sector.

Opulantpharmaceuticals offers API Products, API Intermediates, and Speciality Chemicals.

Opulantpharmaceuticals operates through Opulant Pharmaceuticals Private Limited.

The legal entities of Opulantpharmaceuticals currently have 2 directors, including Rakesh Kasula, Kasularaghavarao.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available